The effect of high‐fibre diets on glycaemic control in women with diabetes in pregnancy: A systematic review and meta‐analysis
Diabetic Medicine · 2025
DOI: 10.1111/dme.15435 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Diabetic Medicine, 2025. Verfasst von Danielle Jones und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, UK. Hauptthemen laut MEDLINE: Blood Glucose, Diabetes Mellitus, Type 2, Dietary Fiber, Glycemic Control. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Dietary fibre improves glycaemic control in type 2 diabetes, but its therapeutic role in women with diabetes in pregnancy is unclear. We assessed the effect of dietary fibre on markers of glycaemic control in women with diabetes in pregnancy.
Methods
We searched four databases (Cochrane Library, MEDLINE, Embase and Web of Science) to identify RCTs exploring the effect of dietary fibre, high‐fibre diets or fibre supplementation on fasting blood glucose (FBG), 2‐h postprandial blood glucose (PBG) and requirement for insulin therapy, among other glycaemic makers in pregnant women with diabetes. Data were pooled for each outcome to calculate change from baseline mean (SD) and overall mean difference (MD) between control and intervention groups.
Results
Of 1462 identified studies, data from 20 eligible trials containing 1061 participants were pooled. On meta‐analysis, a higher fibre intake was associated with reduced FBG (MD: −0.35 mmol/L, 95% CI: −0.53, −0.18, p < 0.01), PBG (MD: −0.90 mmol/L, 95% CI: −1.39, −0.40, p < 0.01) and requirement for insulin (OR: 0.24, 95% CI: 0.13, 0.46, p < 0.01). There was significant heterogeneity for FBG and PBG (>90%), attributable to differences in Intervention type for PBG (Dietary Approach to Stop Hypertension [DASH] diet, low glycaemic index, supplement; p < 0.01) and study duration (for FBG: p = 0.002; not for PBG). Studies were mostly scored as high risk of bias due to lack of blinding (Cochrane Risk of Bias Tool v.2.0).
Conclusion
High‐quality dietary intervention studies in pregnancy are lacking. Our results suggest that high‐fibre diets improve fasting and postprandial glycaemia and reduce the likelihood of requiring insulin in women with diabetes in pregnancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Metabolic Science-Metabolic Research Laboratories, University of Cambridge, Cambridge, UK.
- Barnet Hospital, Royal Free London NHS Foundation Trust, Wellhouse Lane, London, UK.
- MRC Epidemiology Unit, University of Cambridge, Cambridge, UK.
- Leicester Real World Evidence Unit, Diabetes Research Centre, Leicester General Hospital, University of Leicester, Leicester, UK.
- Leicester Diabetes Centre, Leicester General Hospital, University of Leicester, Leicester, UK.
- University Hospitals Leicester NHS Trust, Leicester General Hospital, Leicester, UK.
ORCID-Profile: Danielle Jones, Claire L Meek
Zitieren
APA
Jones, D., Kyriakidou, A., Cooper, L., Atta, N., Tobolska, P., Smith, S., Turner, E., Petry, C., Gillies, C., & Meek, C. L. (2025). The effect of high‐fibre diets on glycaemic control in women with diabetes in pregnancy: A systematic review and meta‐analysis. Diabetic Medicine. https://doi.org/10.1111/dme.15435
Vancouver
Jones D, Kyriakidou A, Cooper L, Atta N, Tobolska P, Smith S, et al. The effect of high‐fibre diets on glycaemic control in women with diabetes in pregnancy: A systematic review and meta‐analysis. Diabetic Medicine. 2025. doi:10.1111/dme.15435
BibTeX
@article{Jones2025,
author = {Jones, Danielle and Kyriakidou, Anna and Cooper, Louise and Atta, Nooria and Tobolska, Patrycja and Smith, Suzanne and Turner, Elizabeth and Petry, Clive and Gillies, Clare and Meek, Claire L},
title = {The effect of high‐fibre diets on glycaemic control in women with diabetes in pregnancy: A systematic review and meta‐analysis},
journal = {Diabetic Medicine},
year = {2025},
doi = {10.1111/dme.15435}
}
EUVIMED